Orange Book product · Generic (ANDA)
METHYCLOTHIAZIDE
METHYCLOTHIAZIDE
At a glance
Aug 18, 1988
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Aug 18, 1988
38 yr 5 mo ago
Today
Pharmaceutical detail
Active ingredient
METHYCLOTHIAZIDE
Strength
2.5MG
Dosage form
TABLET
Route
ORAL
TE code
Not listed
Application
ANDA 089835
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of METHYCLOTHIAZIDE
- —AQUATENSENBrand (NDA)
NDA 017364 · MEDPOINTE PHARM HLC
- —ENDURONBrand (NDA)
NDA 012524 · ABBVIE
- 1988METHYCLOTHIAZIDEGeneric (ANDA)
ANDA 089837 · CHARTWELL RX
- 1986METHYCLOTHIAZIDEGeneric (ANDA)
ANDA 089135 · PAR PHARM
- 1986METHYCLOTHIAZIDEGeneric (ANDA)
ANDA 089136 · PAR PHARM
- 1985METHYCLOTHIAZIDEGeneric (ANDA)
ANDA 088745 · USL PHARMA
- 1984METHYCLOTHIAZIDEGeneric (ANDA)
ANDA 088750 · WATSON LABS
- 1984METHYCLOTHIAZIDEGeneric (ANDA)
ANDA 088724 · WATSON LABS
- 1982METHYCLOTHIAZIDEGeneric (ANDA)
ANDA 087671 · MYLAN
- 1982METHYCLOTHIAZIDEGeneric (ANDA)
ANDA 087672 · PHARMOBEDIENT
- 1982METHYCLOTHIAZIDEGeneric (ANDA)
ANDA 087913 · IVAX PHARMS
- 1982METHYCLOTHIAZIDEGeneric (ANDA)
ANDA 087786 · IVAX PHARMS
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
